Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

Eli L. Diamond, Lorenzo Dagna, David M. Hyman, Giulio Cavalli, Filip Janku, Juvianee Estrada-Veras, Marina Ferrarini, Omar Abdel-Wahab, Mark L. Heaney, Paul J. Scheel, Nancy K. Feeley, Elisabetta Ferrero, Kenneth L. McClain, Augusto Vaglio, Thomas Colby, Laurent Arnaud, Julien Haroche

Research output: Contribution to journalArticle

224 Citations (Scopus)

Abstract

Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAFV600E mutations in >50% of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Although ~500 to 550 cases have been describedin the literature todate, increased physician awareness has driven a dramatic increase in ECD diagnoses over the last decade. ECD frequently involves multiple organ systems and has historically lacked effective therapies. Given the protean clinical manifestations and the lack of a consensus-derived approach for the management of ECD, we provide here the first multidisciplinary consensus guidelines for the clinical management of ECD. These recommendationswere outlined at the First International Medical Symposium for ECD, comprised of a comprehensive group of international academicians with expertise in the pathophysiology and therapy of ECD. Detailed recommendations on the initial clinical, laboratory, and radiographic assessment of ECD patients are presented in addition to treatment recommendations based on critical appraisal of the literature and clinical experience. These formalized consensus descriptions will hopefully facilitate ongoing and future research efforts in this disorder.

Original languageEnglish
Pages (from-to)483-492
Number of pages10
JournalBlood
Volume124
Issue number4
DOIs
Publication statusPublished - Jul 24 2014

Fingerprint

Erdheim-Chester Disease
Guidelines
Histiocytosis
Clinical laboratories
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Diamond, E. L., Dagna, L., Hyman, D. M., Cavalli, G., Janku, F., Estrada-Veras, J., ... Haroche, J. (2014). Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood, 124(4), 483-492. https://doi.org/10.1182/blood-2014-03-561381

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. / Diamond, Eli L.; Dagna, Lorenzo; Hyman, David M.; Cavalli, Giulio; Janku, Filip; Estrada-Veras, Juvianee; Ferrarini, Marina; Abdel-Wahab, Omar; Heaney, Mark L.; Scheel, Paul J.; Feeley, Nancy K.; Ferrero, Elisabetta; McClain, Kenneth L.; Vaglio, Augusto; Colby, Thomas; Arnaud, Laurent; Haroche, Julien.

In: Blood, Vol. 124, No. 4, 24.07.2014, p. 483-492.

Research output: Contribution to journalArticle

Diamond, EL, Dagna, L, Hyman, DM, Cavalli, G, Janku, F, Estrada-Veras, J, Ferrarini, M, Abdel-Wahab, O, Heaney, ML, Scheel, PJ, Feeley, NK, Ferrero, E, McClain, KL, Vaglio, A, Colby, T, Arnaud, L & Haroche, J 2014, 'Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease', Blood, vol. 124, no. 4, pp. 483-492. https://doi.org/10.1182/blood-2014-03-561381
Diamond, Eli L. ; Dagna, Lorenzo ; Hyman, David M. ; Cavalli, Giulio ; Janku, Filip ; Estrada-Veras, Juvianee ; Ferrarini, Marina ; Abdel-Wahab, Omar ; Heaney, Mark L. ; Scheel, Paul J. ; Feeley, Nancy K. ; Ferrero, Elisabetta ; McClain, Kenneth L. ; Vaglio, Augusto ; Colby, Thomas ; Arnaud, Laurent ; Haroche, Julien. / Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. In: Blood. 2014 ; Vol. 124, No. 4. pp. 483-492.
@article{86182bc17b0e40bab38272ff030003aa,
title = "Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease",
abstract = "Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAFV600E mutations in >50{\%} of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Although ~500 to 550 cases have been describedin the literature todate, increased physician awareness has driven a dramatic increase in ECD diagnoses over the last decade. ECD frequently involves multiple organ systems and has historically lacked effective therapies. Given the protean clinical manifestations and the lack of a consensus-derived approach for the management of ECD, we provide here the first multidisciplinary consensus guidelines for the clinical management of ECD. These recommendationswere outlined at the First International Medical Symposium for ECD, comprised of a comprehensive group of international academicians with expertise in the pathophysiology and therapy of ECD. Detailed recommendations on the initial clinical, laboratory, and radiographic assessment of ECD patients are presented in addition to treatment recommendations based on critical appraisal of the literature and clinical experience. These formalized consensus descriptions will hopefully facilitate ongoing and future research efforts in this disorder.",
author = "Diamond, {Eli L.} and Lorenzo Dagna and Hyman, {David M.} and Giulio Cavalli and Filip Janku and Juvianee Estrada-Veras and Marina Ferrarini and Omar Abdel-Wahab and Heaney, {Mark L.} and Scheel, {Paul J.} and Feeley, {Nancy K.} and Elisabetta Ferrero and McClain, {Kenneth L.} and Augusto Vaglio and Thomas Colby and Laurent Arnaud and Julien Haroche",
year = "2014",
month = "7",
day = "24",
doi = "10.1182/blood-2014-03-561381",
language = "English",
volume = "124",
pages = "483--492",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

AU - Diamond, Eli L.

AU - Dagna, Lorenzo

AU - Hyman, David M.

AU - Cavalli, Giulio

AU - Janku, Filip

AU - Estrada-Veras, Juvianee

AU - Ferrarini, Marina

AU - Abdel-Wahab, Omar

AU - Heaney, Mark L.

AU - Scheel, Paul J.

AU - Feeley, Nancy K.

AU - Ferrero, Elisabetta

AU - McClain, Kenneth L.

AU - Vaglio, Augusto

AU - Colby, Thomas

AU - Arnaud, Laurent

AU - Haroche, Julien

PY - 2014/7/24

Y1 - 2014/7/24

N2 - Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAFV600E mutations in >50% of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Although ~500 to 550 cases have been describedin the literature todate, increased physician awareness has driven a dramatic increase in ECD diagnoses over the last decade. ECD frequently involves multiple organ systems and has historically lacked effective therapies. Given the protean clinical manifestations and the lack of a consensus-derived approach for the management of ECD, we provide here the first multidisciplinary consensus guidelines for the clinical management of ECD. These recommendationswere outlined at the First International Medical Symposium for ECD, comprised of a comprehensive group of international academicians with expertise in the pathophysiology and therapy of ECD. Detailed recommendations on the initial clinical, laboratory, and radiographic assessment of ECD patients are presented in addition to treatment recommendations based on critical appraisal of the literature and clinical experience. These formalized consensus descriptions will hopefully facilitate ongoing and future research efforts in this disorder.

AB - Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAFV600E mutations in >50% of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Although ~500 to 550 cases have been describedin the literature todate, increased physician awareness has driven a dramatic increase in ECD diagnoses over the last decade. ECD frequently involves multiple organ systems and has historically lacked effective therapies. Given the protean clinical manifestations and the lack of a consensus-derived approach for the management of ECD, we provide here the first multidisciplinary consensus guidelines for the clinical management of ECD. These recommendationswere outlined at the First International Medical Symposium for ECD, comprised of a comprehensive group of international academicians with expertise in the pathophysiology and therapy of ECD. Detailed recommendations on the initial clinical, laboratory, and radiographic assessment of ECD patients are presented in addition to treatment recommendations based on critical appraisal of the literature and clinical experience. These formalized consensus descriptions will hopefully facilitate ongoing and future research efforts in this disorder.

UR - http://www.scopus.com/inward/record.url?scp=84904871709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904871709&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-03-561381

DO - 10.1182/blood-2014-03-561381

M3 - Article

C2 - 24850756

AN - SCOPUS:84904871709

VL - 124

SP - 483

EP - 492

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -